These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34060626)

  • 1. Western lifestyle as a driver of dysbiosis in colorectal cancer.
    Foegeding NJ; Jones ZS; Byndloss MX
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34060626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?
    Ternes D; Karta J; Tsenkova M; Wilmes P; Haan S; Letellier E
    Trends Microbiol; 2020 May; 28(5):401-423. PubMed ID: 32298617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of preoperative gut microbiota on colorectal anastomotic leakage: preliminary results.
    Palmisano S; Campisciano G; Iacuzzo C; Bonadio L; Zucca A; Cosola D; Comar M; de Manzini N
    Updates Surg; 2020 Dec; 72(4):1013-1022. PubMed ID: 32062786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. It takes a village: microbiota, parainflammation, paligenosis and bystander effects in colorectal cancer initiation.
    Wang X; Undi RB; Ali N; Huycke MM
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 33969420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Power of the Gut Microbiome: Exploring New Perspectives in Colorectal Cancer Therapy].
    Takeda M; Doki Y
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):608-612. PubMed ID: 39009515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways.
    Hagland HR; Søreide K
    Cancer Lett; 2015 Jan; 356(2 Pt A):273-80. PubMed ID: 24614287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking Diet to Aid Human-Microbe Symbiosis.
    Derrien M; Veiga P
    Trends Microbiol; 2017 Feb; 25(2):100-112. PubMed ID: 27916707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
    Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
    Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome in tumorigenesis and therapy of colorectal cancer.
    Wang L; Yu KC; Hou YQ; Guo M; Yao F; Chen ZX
    J Cell Physiol; 2023 Jan; 238(1):94-108. PubMed ID: 36409765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention.
    Song M; Chan AT
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):275-289. PubMed ID: 30031175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet, microbiota, and dysbiosis: a 'recipe' for colorectal cancer.
    Vipperla K; O'Keefe SJ
    Food Funct; 2016 Apr; 7(4):1731-40. PubMed ID: 26840037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome Dysbiosis, Dietary Intake and Lifestyle-Associated Factors Involve in Epigenetic Modulations in Colorectal Cancer: A Narrative Review.
    Kwao-Zigah G; Bediako-Bowan A; Boateng PA; Aryee GK; Abbang SM; Atampugbire G; Quaye O; Tagoe EA
    Cancer Control; 2024; 31():10732748241263650. PubMed ID: 38889965
    [No Abstract]   [Full Text] [Related]  

  • 16. Nutraceuticals in colorectal cancer: A mechanistic approach.
    Rossi M; Mirbagheri SEYEDS; Keshavarzian A; Bishehsari F
    Eur J Pharmacol; 2018 Aug; 833():396-402. PubMed ID: 29935172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
    Hou X; Zheng Z; Wei J; Zhao L
    Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Fong W; Li Q; Yu J
    Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
    Fan X; Jin Y; Chen G; Ma X; Zhang L
    Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.